These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18454321)

  • 1. Microparticles for inhalational delivery of antipseudomonal antibiotics.
    Tsifansky MD; Yeo Y; Evgenov OV; Bellas E; Benjamin J; Kohane DS
    AAPS J; 2008 Jun; 10(2):254-60. PubMed ID: 18454321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.
    Yang Y; Tsifansky MD; Wu CJ; Yang HI; Schmidt G; Yeo Y
    Pharm Res; 2010 Jan; 27(1):151-60. PubMed ID: 19847626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infection.
    Adhikari BR; Sinha S; Gordon KC; Das SC
    Int J Pharm; 2022 Jun; 621():121799. PubMed ID: 35525472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cospray dried antibiotics for dry powder lung delivery.
    Adi H; Young PM; Chan HK; Stewart P; Agus H; Traini D
    J Pharm Sci; 2008 Aug; 97(8):3356-66. PubMed ID: 17990305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release antibiotics for dry powder lung delivery.
    Adi H; Young PM; Chan HK; Salama R; Traini D
    Drug Dev Ind Pharm; 2010 Jan; 36(1):119-26. PubMed ID: 19656005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.
    Yang Y; Tsifansky MD; Shin S; Lin Q; Yeo Y
    Biotechnol Bioeng; 2011 Jun; 108(6):1441-9. PubMed ID: 21488050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
    Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
    Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process.
    Farhangi M; Mahboubi A; Kobarfard F; Vatanara A; Mortazavi SA
    Pharm Dev Technol; 2019 Jun; 24(5):584-592. PubMed ID: 30431373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Yang J; Liu Z; Gutierrez C; Aymard G; Rouby JJ;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):106-15. PubMed ID: 21474643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery.
    Silva DM; Paleco R; Traini D; Sencadas V
    Int J Pharm; 2018 Aug; 547(1-2):114-121. PubMed ID: 29803795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.
    Antonela Antoniu S
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1439-46. PubMed ID: 23253321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.
    Ferrari F; Lu Q; Girardi C; Petitjean O; Marquette CH; Wallet F; Rouby JJ;
    Intensive Care Med; 2009 Oct; 35(10):1792-800. PubMed ID: 19652947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
    Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.